Tango Therapeutics, Inc. (TNGX)

NASDAQ: TNGX · Real-Time Price · USD

31.06

+0.54 (1.77%)

At close: Jul 10, 2026, 4:00 PM EDT

31.50

+0.44 (1.42%)

After-hours: Jul 10, 2026, 7:59 PM EDT

Tango Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	4,493	1,204	333	1,012	639	958
Market Cap Growth	733.97%	261.82%	-67.10%	58.27%	-33.29%	107.49%
Enterprise Value	4,146	894.86	111.46	713.84	314.3	474.57
Last Close Price	31.06	8.86	3.09	9.90	7.25	10.94
PS Ratio	78.83	19.31	7.91	27.70	25.72	25.87
PB Ratio	11.44	3.48	1.67	4.00	2.56	2.78
P/TBV Ratio	9.99	2.97	1.69	3.70	2.55	1.97
EV/Sales Ratio	72.74	14.34	2.65	19.54	12.64	12.81
Debt / Equity Ratio	0.08	0.09	0.17	0.15	0.16	0
Net Debt / Equity Ratio	-0.89	-0.89	-1.11	-1.18	-1.30	-1.40
Net Debt / EBITDA Ratio	3.01	2.84	1.55	2.67	2.97	8.44
Net Debt / FCF Ratio	2.44	2.21	1.67	2.49	2.78	7.88
Asset Turnover	0.14	0.17	0.12	0.09	0.05	0.10
Quick Ratio	26.51	15.83	6.76	7.33	6.63	11.97
Current Ratio	27.38	16.32	6.98	7.54	6.76	12.10
Return on Equity (ROE)	-29.09%	-37.23%	-57.41%	-40.39%	-36.37%	-30.08%
Return on Assets (ROA)	-28.18%	-31.12%	-40.43%	-27.18%	-23.71%	-16.37%
Return on Invested Capital (ROIC)	-290.04%	-1513.66%	-	-	-	-
Return on Capital Employed (ROCE)	-29.44%	-33.96%	-45.86%	-30.96%	-26.43%	-18.60%
Buyback Yield / Dilution	-13.42%	-6.35%	-15.50%	-7.69%	-41.40%	-94.50%
Total Shareholder Return	-13.42%	-6.35%	-15.50%	-7.69%	-41.40%	-94.50%

SEC Filings: 10-K · 10-Q